K. Larsson

发表

A Human Protein Atlas for Normal and Cancer Tissues Based on Antibody Proteomics*

Erik K. Malm, F. Pontén, M. Uhlén, 2005, Molecular & Cellular Proteomics.

Organic electronics for precise delivery of neurotransmitters to modulate mammalian sensory function.

M. Berggren, K. Larsson, D. Simon, 2009, Nature materials.

Towards a human proteome atlas: High‐throughput generation of mono‐specific antibodies for tissue profiling

F. Pontén, M. Uhlén, C. Kampf, 2005, Proteomics.

Multiplexed PrEST immunization for high-throughput affinity proteomics.

M. Uhlén, P. Nilsson, K. Larsson, 2006, Journal of immunological methods.

Organic bioelectronics for electronic-to-chemical translation in modulation of neuronal signaling and machine-to-brain interfacing.

Agneta Richter-Dahlfors, Peter Kjäll, Karin C Larsson, 2013, Biochimica et biophysica acta.

From DEPARTMENT OF NEUROSCIENCE Karolinska Institutet, Stockholm, Sweden ORGANIC BIOELECTRONIC DEVICES TO CONTROL CELL SIGNALLING

K. Larsson, 2012 .

Phosphodiesterase 4A confers resistance to PGE2‐mediated suppression in CD25+/CD54+ NK cells

Shi-Yong Neo, K. Larsson, Yihai Cao, 2021, EMBO reports.

Inhibition of microsomal prostaglandin E synthase-1 as targeted therapy in cancer treatment.

K. Larsson, P. Jakobsson, 2015, Prostaglandins & other lipid mediators.

COX/mPGES-1/PGE2 pathway depicts an inflammatory-dependent high-risk neuroblastoma subset

K. Larsson, P. Jakobsson, H. Idborg, 2015, Proceedings of the National Academy of Sciences.

Precise Neurotransmitter-Mediated Communication with Neurons In Vitro and In Vivo Using Organic Electronics

M. Berggren, K. Larsson, D. Simon, 2010 .

An ion bipolar junction transistor

M. Berggren, K. Larsson, K. Tybrandt, 2012 .

Targeting the COX/mPGES-1/PGE2 Pathway in Neuroblastoma.

K. Larsson, P. Jakobsson, P. Kogner, 2019, Advances in experimental medicine and biology.

Inhibition of Microsomal Prostaglandin E Synthase-1 in Cancer-Associated Fibroblasts Suppresses Neuroblastoma Tumor Growth

K. Larsson, P. Jakobsson, M. Korotkova, 2018, EBioMedicine.

Effects of microsomal prostaglandin E synthase‐1 inhibition on resistance artery tone in patients with end stage kidney disease

K. Larsson, P. Stenvinkel, Per-Johan Jakobsson, 2021, British journal of pharmacology.

Deletion of mPGES-1 affects platelet functions in mice.

K. Larsson, P. Jakobsson, M. Korotkova, 2016, Clinical science.

Slice Preparation, Organotypic Tissue Culturing and Luciferase Recording of Clock Gene Activity in the Suprachiasmatic Nucleus

K. Larsson, G. Lundkvist, A. Johansson, 2011, Journal of visualized experiments : JoVE.

MYC inhibition induces metabolic changes leading to accumulation of lipid droplets in tumor cells

K. Larsson, J. Lehtiö, P. Jakobsson, 2013, Proceedings of the National Academy of Sciences.

Novel antigen design for the generation of antibodies to G-protein-coupled receptors.

T. Hökfelt, C. Lindskog, P. Angelidou, 2011, Journal of immunological methods.

Establishment of an in vitro 3D model for neuroblastoma enables preclinical investigation of combined tumor‐stroma drug targeting

K. Larsson, P. Jakobsson, Julia Steinmetz, 2020, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

Inhibition of mPGES-1 or COX-2 Results in Different Proteomic and Lipidomic Profiles in A549 Lung Cancer Cells

K. Kultima, K. Larsson, C. Wheelock, 2019, Front. Pharmacol..

Small extracellular vesicle‐derived miR‐574‐5p regulates PGE2‐biosynthesis via TLR7/8 in lung cancer

K. Larsson, R. Savai, A. Guenther, 2021, Journal of extracellular vesicles.

Generation and characterization of antibodies for proteomics research

K. Larsson, 2009 .

Characterization of PrEST-based antibodies towards human Cytokeratin-17.

J. Schwenk, L. Berglund, C. Eriksson, 2009, Journal of immunological methods.

Targeting of the MYCN Protein with Small Molecule c-MYC Inhibitors

K. Larsson, E. Prochownik, M. Henriksson, 2014, PloS one.

Publisher Correction: A DHODH inhibitor increases p53 synthesis and enhances tumor cell killing by p53 degradation blockage

Gergana Popova, K. Larsson, A. Thompson, 2018, Nature Communications.

A DHODH inhibitor increases p53 synthesis and enhances tumor cell killing by p53 degradation blockage

Gergana Popova, K. Larsson, A. Thompson, 2018, Nature Communications.

Organic bioelectronic devices to control cell signalling

K. Larsson, 2012 .

Organic bioelectronics in nanomedicine.

Magnus Berggren, Agneta Richter-Dahlfors, Karl Svennersten, 2011, Biochimica et biophysica acta.

Biological characterization of new inhibitors of microsomal PGE synthase‐1 in preclinical models of inflammation and vascular tone

K. Larsson, P. Jakobsson, R. Morgenstern, 2019, British journal of pharmacology.

An organic electronic biomimetic neuron enables auto-regulated neuromodulation.

Magnus Berggren, Agneta Richter-Dahlfors, Gustav Burström, 2015, Biosensors & bioelectronics.

Translating Electronic Currents to Precise Acetylcholine–Induced Neuronal Signaling Using an Organic Electrophoretic Delivery Device

Edwin Jager, Magnus Berggren, Agneta Richter-Dahlfors, 2009 .

An organic electronic ion pump to regulate intracellular signaling at high spatiotemporal resolution

M. Berggren, K. Larsson, D. Simon, 2009, TRANSDUCERS 2009 - 2009 International Solid-State Sensors, Actuators and Microsystems Conference.

Ion bipolar junction transistors

Magnus Berggren, Agneta Richter-Dahlfors, Klas Tybrandt, 2010, Proceedings of the National Academy of Sciences.

High‐content screening of drug combinations of an mPGES‐1 inhibitor in multicellular tumor spheroids leads to mechanistic insights into neuroblastoma chemoresistance

K. Larsson, B. Seashore-Ludlow, Ming-Mei Shang, 2023, Molecular oncology.